Nama Insights

Windward Bio Group AG Common (WWB)

Healthcare · Biotechnology · NASDAQ

Windward Bio Group AG Common (WWB) is a Healthcare company in the Biotechnology industry. It has a market capitalization of $1.39B. Nama's AI scorecard rates it Hold.
AI scorecard
Hold
The sections balance. As of Nov 20, 2026.
Shariah screen
Can't Tell
A figure the screen needs is missing, so it can't tell.
Off its high
-28.5%
How far the last close sits under the highest price of the past five years.
Market cap$1.39B
Trailing P/E—
Price / book1.4
Price / sales—
FCF yield—
Dividend yield—
Gross margin0.0%
Operating margin0.0%
Net margin0.0%
Revenue growth (YoY)—
Revenue growth (3-yr annual)—
EPS growth (YoY)—
FCF/share growth (YoY)—
Beta—
ExchangeNASDAQ
SectorHealthcare
IndustryBiotechnology

Biotechnology peers

TickerCompanyMarket capP/E
VRTX Vertex Pharmaceuticals $132.01B 27.4
REGN Regeneron Pharmaceuticals $95.52B 16.7
MRNA Moderna $80.65B —
ARGX argenx $59.24B 32.9
ONC BeOne Medicines $45.66B 50.8
RPRX Royalty Pharma $38.94B 12.8
RVMD Revolution Medicines $34.48B —
INSM Insmed $31.69B —
Explore live WWB data on Nama Insights →

WWB FAQ

Is WWB a buy?
Nama's AI scorecard currently rates Windward Bio Group AG Common Hold, a call computed from its profitability, cash generation, growth, valuation and balance sheet. It is a research reading, not investment advice.
Is WWB Shariah compliant?
Nama's AAOIFI-style screen reads Windward Bio Group AG Common as Can't Tell. A figure the screen needs is missing, so it can't tell.